- Home
- / Primmune Therapeutics
Primmune Therapeutics
Total Funding
$8.5 M
Primmune Therapeutics Summary
Company Summary
- Overview
- Primmune Therapeutics is a company that provides drug design and development solutions. It offers a toll-like receptor 7 (TLR7) agonist to stimulate innate immunity in cancer immunotherapy.
- Type
- Private
- Status
- Active
- Founded
- 2017
- HQ
- Carlsbad, CA, US | view all locations
- Website
- https://www.primmunerx.com
- Cybersecurity rating
Table of Contents
Key People
LocationsView all
1 location detected
Carlsbad, CA HQ
United States
2011 Palomar Airport Rd Suite 101